These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1897528)

  • 1. Why does the human factor IX gene have a G + C content of 40%?
    Bottema CD; Bottema MJ; Ketterling RP; Yoon HS; Janco RL; Phillips JA; Sommer SS
    Am J Hum Genet; 1991 Oct; 49(4):839-50. PubMed ID: 1897528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rates of G:C-->T:A and G:C-->C:G transversions at CpG dinucleotides in the human factor IX gene.
    Ketterling RP; Vielhaber E; Sommer SS
    Am J Hum Genet; 1994 May; 54(5):831-5. PubMed ID: 8178822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pattern of spontaneous germ-line mutation: relative rates of mutation at or near CpG dinucleotides in the factor IX gene.
    Bottema CD; Ketterling RP; Vielhaber E; Yoon HS; Gostout B; Jacobson DP; Shapiro A; Sommer SS
    Hum Genet; 1993 Jun; 91(5):496-503. PubMed ID: 8314564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene.
    Koeberl DD; Bottema CD; Ketterling RP; Bridge PJ; Lillicrap DP; Sommer SS
    Am J Hum Genet; 1990 Aug; 47(2):202-17. PubMed ID: 2198809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the underlying pattern of human germline mutations: lessons from the factor IX gene.
    Sommer SS
    FASEB J; 1992 Jul; 6(10):2767-74. PubMed ID: 1634040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionally important regions of the factor IX gene have a low rate of polymorphism and a high rate of mutation in the dinucleotide CpG.
    Koeberl DD; Bottema CD; Buerstedde JM; Sommer SS
    Am J Hum Genet; 1989 Sep; 45(3):448-57. PubMed ID: 2773937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in hemophilia B patients: a Seattle series.
    Chen SH; Zhang M; Lovrien EW; Scott CR; Thompson AR
    Hum Genet; 1991 Jun; 87(2):177-82. PubMed ID: 2066105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements.
    Bottema CD; Ketterling RP; Ii S; Yoon HS; Phillips JA; Sommer SS
    Am J Hum Genet; 1991 Oct; 49(4):820-38. PubMed ID: 1680287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation rates in humans. II. Sporadic mutation-specific rates and rate of detrimental human mutations inferred from hemophilia B.
    Giannelli F; Anagnostopoulos T; Green PM
    Am J Hum Genet; 1999 Dec; 65(6):1580-7. PubMed ID: 10577911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline origins in the human F9 gene: frequent G:C-->A:T mosaicism and increased mutations with advanced maternal age.
    Ketterling RP; Vielhaber E; Li X; Drost J; Schaid DJ; Kasper CK; Phillips JA; Koerper MA; Kim H; Sexauer C; Gruppo R; Ambriz R; Paredes R; Sommer SS
    Hum Genet; 1999 Dec; 105(6):629-40. PubMed ID: 10647899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pattern of factor IX germ-line mutation in Asians is similar to that of Caucasians.
    Bottema CD; Ketterling RP; Yoon HS; Sommer SS
    Am J Hum Genet; 1990 Nov; 47(5):835-41. PubMed ID: 2220823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots.
    Green PM; Montandon AJ; Bentley DR; Ljung R; Nilsson IM; Giannelli F
    Nucleic Acids Res; 1990 Jun; 18(11):3227-31. PubMed ID: 1972560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of haemophilia B database and strategies for identification of common point mutations in the factor IX gene.
    Mukherjee S; Mukhopadhyay A; Chaudhuri K; Ray K
    Haemophilia; 2003 Mar; 9(2):187-92. PubMed ID: 12614370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methylation of the factor IX gene--a basic reason for the mutation causing hemophilia B].
    Mazin AL
    Mol Biol (Mosk); 1995; 29(1):71-90. PubMed ID: 7723765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human germline mutation in the factor IX gene.
    Sommer SS; Scaringe WA; Hill KA
    Mutat Res; 2001 Nov; 487(1-2):1-17. PubMed ID: 11595404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline mutations in the factor IX gene: a comparison of the pattern in Caucasians and non-Caucasians.
    Gostout B; Vielhaber E; Ketterling RP; Yoon HS; Bottema CD; Kasper CK; Koerper MA; Sommer SS
    Hum Mol Genet; 1993 Mar; 2(3):293-8. PubMed ID: 8499919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of polymorphisms at cytosine phosphoguanadine dinucleotides and diagnosis of haemophilia B carriers.
    Winship PR; Rees DJ; Alkan M
    Lancet; 1989 Mar; 1(8639):631-4. PubMed ID: 2564457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model.
    Sved J; Bird A
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4692-6. PubMed ID: 2352943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The high frequency of the -6G-->A factor IX promoter mutation is the result both of a founder effect and recurrent mutation at a CpG dinucleotide.
    Morgan GE; Figueiredo MS; Winship PR; Baker R; Bolton-Maggs PH; Brownlee GG
    Br J Haematol; 1995 Mar; 89(3):672-4. PubMed ID: 7734378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single base pair deletion in the promoter region of the factor IX gene is associated with haemophilia B.
    Hall AJ; Chuansumrit A; Peake IR; Winship PR
    Thromb Haemost; 1994 Dec; 72(6):799-803. PubMed ID: 7740444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.